ZAP Surgical Systems
ZAP Surgical Systems, based in San Carlos, California, is a medical robotics company founded in 2014 by neurosurgeon John R.
About
ZAP Surgical Systems, based in San Carlos, California, is a medical robotics company founded in 2014 by neurosurgeon John R. Adler, inventor of the CyberKnife, with Foxconn founder Terry Gou as co-founder and anchor investor. It builds the self-shielded gyroscopic ZAP-X radiosurgery robot and the ZAP-Axon treatment-planning system for non-invasive treatment of brain tumors, cleared by the FDA, CE and Japanese regulators.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Investor· 2
Founders / team· 2
Funding history
- 2026-10-19New funding round$36M
Investors · Catalio Capital Management, BahealSource · businesswire.com ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- ZAP Surgical Systems
ZAP Surgical Systems, based in San Carlos, California, is a medical robotics company founded in 2014 by neurosurgeon John R. Adler, inventor of the CyberKnife, with Foxconn founder Terry Gou as co-founder and anchor investor. It builds the self-shielded gyroscopic ZAP-X radiosurgery robot and the ZAP-Axon treatment-planning system for non-invasive treatment of brain tumors, cleared by the FDA, CE and Japanese regulators.
2026-10
—
United States
BusinessLatest roundTotal raisedDate- Coherence Neuro
Closed-loop brain-computer interface system SOMA, using a wireless implant to decode tumor electrical signals in real time and deliver personalized electrical stimulation to treat brain tumors and other cancers
Series A · 2026-10
— - Aurenar
V-Link, a non-invasive, single-use neuromodulation platform that uses low-energy transcutaneous auricular vagus nerve stimulation via the outer ear to modulate inflammation and reduce fatal complications in ICU patients; first indication is cerebral vasospasm after aneurysmal subarachnoid hemorrhage; FDA Breakthrough Device designation
Seed · $6M · 2026-07
$6M - Nervonik
Implantable peripheral nerve stimulation devices using electrical signals and real-time sensing for personalized chronic pain treatment
Series B · $53M · 2026-05
$53M
China
BusinessLatest roundTotal raisedDate- 深度医疗
R&D and manufacturing of the FUNZAR microsurgery robot for hospital ophthalmology, orthopedics, neurosurgery, plastic surgery and other departments, eliminating precision limits caused by hand tremor in microsurgery.
Series B · 2026-10
— - 德壹医疗
AI physiotherapy robots for tuina massage, moxibustion, shockwave therapy and more, used by TCM hospitals, rehabilitation and physiotherapy departments, and elderly care facilities
Series A · 2026-07
— - BCI-Sonics
Non-invasive AI ultrasound brain-computer interface (transcranial focused ultrasound neuromodulation + multimodal brain reading and AI neural decoding)
Series A · $42M · 2026-09
$42M
Europe
BusinessLatest roundTotal raisedDate- Nami Surgical
Miniature ultrasonic medical devices for surgery; high-performance small ultrasonic scalpels designed to overcome obstacles in robot-assisted surgery
Undisclosed · $4M · 2024-05
$4M - Soundsafe Care
Robotic focused ultrasound devices for noninvasive tumor ablation, launching first with veterinary certification, then expanding to human tumor treatment.
$2M
$2M - XRlabs
XRlabs SIM (CT/MRI to 3D digital twins for surgical rehearsal) and SurgicalOS (real-time AI video and instrument tracking) for hospitals and surgeons
Seed · 2026-10
—
Other / unspecified
BusinessLatest roundTotal raisedDate- Scopia Surgical
AI surgical navigation software combining real-time spatial intelligence and patient-specific digital twins for robot-assisted and minimally invasive soft-tissue surgery
Pre-Seed · $3M · 2026-09
$3M - iPreg Inc.
Assisted reproduction devices: SperSort™ biomimetic antibody-free microfluidic sperm sorting chip and companion equipment for fertility centers; also AIVF Consultant, an AI assisted-reproduction Q&A bot
— - Sound Blade Medical
Handheld device that uses focused ultrasound to break down diseased tissue non-invasively
Series A · $17M · 2025-02
$17M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 22 in Silicon Valley
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.